FrancophonIA/ELRC3.0 huggingface dataset:
English: • Swallow your tablet whole, do not chew it, crush it or let it dissolve in your mouth.
Slovenian: • Tableto pogoltnite celo - ne žvečite in ne prelamljajte tablete ter ne pustite, da se raztopi v ustih.
English: - Patients should not chew or suck the tablet, because of a potential for oropharyngeal ulceration
Slovenian: - Bolniki tablet ne smejo žvečiti ali sesati, ker lahko pride do ulceracije žrela.
English: • Acetylsalicylic acid and other non-steroidal anti-inflammatory medicines (NSAIDs) (including ibuprofen, diclofenac sodium and naproxen) may irritate the stomach and intestine.
Slovenian: • Acetilsalicilno kislino in druga nesteroidna protivnetna zdravila (NSAID, ki vključujejo ibuprofen, natrijev diklofenak in naproksen) lahko dražijo želodec in črevesje.
English: On the basis of the pharmacodynamic and pharmacokinetic profile and reported adverse reactions, it is expected that Bonviva has no or negligible influence on the ability to drive and use machines.
Slovenian: Glede na farmakodinamske in farmakokinetične lastnosti ter poročane neželene učinke pričakujemo, da zdravilo Bonviva nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
English: Bonviva should not be used during pregnancy.
Slovenian: Zdravila Bonviva se med nosečnostjo ne sme uporabljati.
English: Contact your doctor and dentist immediately if you experience any problems with your mouth or teeth such as loose teeth, pain or swelling, or non-healing of sores or discharge, as these could be signs of osteonecrosis of the jaw.
Slovenian: Takoj se posvetujte z zdravnikom in zobozdravnikom, če imate kakršne koli težave v ustih ali z zobmi, kot so majavost zob, bolečina, oteklina in slabo celjenje ali izcedek iz ran, saj so to lahko znaki osteonekroze čeljustnic.
English: Care must be taken not to administer Bonviva injection via intra-arterial or paravenous administration as this could lead to tissue damage.
Slovenian: Potrebna je previdnost, da injekcije zdravila Bonviva ne damo intraarterijsko ali paravensko, ker lahko poškodujemo tkivo.
English: Temporary interruption of Bonviva treatment should be considered until the condition resolves and contributing risk factors are mitigated where possible.
Slovenian: Razmisliti je treba o začasni prekinitvi zdravljenja z zdravilom Bonviva, dokler se stanje ne popravi in zmanjša vpliv ostalih dejavnikov tveganja, če je to mogoče.
English: The usual dose of Bonviva is one tablet once a month.
Slovenian: Običajen odmerek zdravila Bonviva je ena tableta enkrat na mesec.
English: You can drive and use machines as it's expected that Bonviva has no or negligible effect on your ability to drive and use machines.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Lahko vozite in upravljate s stroji, ker pričakujemo, da zdravilo Bonviva nima ali ima zanemarljiv učinek na vašo sposobnost za vožnjo in upravljanje s stroji.
English: • If you have any disturbances of mineral metabolism (such as vitamin D deficiency).
Slovenian: • če imate kakršne koli motnje presnove mineralov (kot je pomanjkanje vitamina D).
English: • Take one Bonviva 150 mg tablet once a month.
Slovenian: • Vzemite eno tableto Bonviva 150 mg enkrat na mesec.
English: In a Phase 1 bioequivalence study conducted in 72 postmenopausal women receiving 150 mg orally every 28 days for a total of four doses, inhibition in serum CTX following the first dose was seen as early as 24 hours post-dose (median inhibition 28 %), with median maximal inhibition (69 %) seen 6 days later.
Slovenian: V fazi I bioekvivalenčne študije pri 72 ženskah v postmenopavzi, ki so prejemale 150 mg peroralno vsakih 28 dni, skupno štiri odmerke, je bila inhibicija serumskega CTX po prvem odmerku opazna že 24 ur po odmerku (mediana inhibicije 28 %) z mediano maksimalne inhibicije (69 %), opaženo 6 dni pozneje.
English: You should wait until the next scheduled dose is due and take it as normal; then, continue taking one tablet once a month on the scheduled days you've marked on your calendar.
Slovenian: Počakajte do naslednjega načrtovanega odmerka in ga vzemite kot običajno, nato jemanje tablet nadaljujte enkrat na mesec, na izbrane dni, ki ste si jih označili na koledarju.
English: They are designed to help your Bonviva tablet reach your stomach quickly, so it's less likely to cause irritation.
Slovenian: Pripravljena so vam v pomoč, da bo tableta zdravila Bonviva laže hitro prišla v želodec in bo možnost draženja manjša.
English: Patients must receive supplemental calcium and vitamin D (see section 4.4 and section 4.5),
Slovenian: Bolniki morajo prejemati dodatke kalcija in vitamina D (glejte poglavje 4.4 in poglavje 4.5).
English: Your doctor may ask you to undergo a dental examination before starting treatment with Bonviva.
Slovenian: Zdravnik vam bo morda svetoval, da pred začetkom zdravljenja z zdravilom Bonviva opravite zobozdravstveni pregled.
English: If you are under dental treatment or will undergo dental surgery (e.g. tooth extractions), inform your doctor about your dental treatment and tell your dentist that you are being treated with Bonviva.
Slovenian: Če vam zdravijo zobe ali boste imeli operacijo (npr. izdrtje zoba), o tem obvestite zdravnika, zobozdravniku pa povejte, da se zdravite z zdravilom Bonviva.
English: Bonviva should be taken after an overnight fast (at least 6 hours) and 1 hour before the first food or drink (other than water) of the day (see section 4.5) or any other oral medicinal products or supplementation (including calcium).
Slovenian: Zdravilo Bonviva je treba vzeti zjutraj na prazen želodec (najmanj 6 ur brez obroka) in 1 uro pred prvim dnevnim obrokom hrane ali pijače, ki ni voda (glejte poglavje 4.5), ali zaužitjem drugih peroralnih zdravil ali dodatkov (vključno s kalcijem).
English: Solution for injection in pre-filled syringe:
Slovenian: Raztopina za injiciranje v napolnjeni injekcijski brizgi:
English: • pain in your muscles, joints, or back
Slovenian: • bolečina v mišicah, sklepih ali hrbtu,
English: The recommended dose of Bonviva for the intravenous injection is 3 mg (1 pre-filled syringe) once every 3 months.
Slovenian: Priporočeni odmerek zdravila Bonviva za intravensko injiciranje je 3 mg (1 napolnjena injekcijska brizga) vsake 3 mesece.
English: If you forget to take Bonviva
Slovenian: Če ste pozabili vzeti zdravilo Bonviva
English: What Bonviva looks like and contents of the pack
Slovenian: Izgled zdravila Bonviva in vsebina pakiranja
English: Hypocalcaemia and other disturbances of bone and mineral metabolism should be assessed and effectively treated before starting Bonviva injection therapy.
Slovenian: Hipokalcemijo in druge motnje v kosteh in presnovi mineralov moramo prepoznati in učinkovito zdraviti pred začetkom intravenskega zdravljenja z zdravilom Bonviva.
English: Bonviva 150 mg film-coated tablets are supplied in blisters (PVC/PVDC, sealed with aluminium foil) containing 1 or 3 tablets.
Slovenian: Filmsko obložene tablete Bonviva 150 mg so na voljo v pretisnih omotih (iz PVC/PVDC, aluminijeve folije) z 1 ali 3 tabletami.
English: • If you have any disturbance of mineral metabolism (such as vitamin D deficiency)
Slovenian: • če imate kakršne koli motnje presnove mineralov (kot je pomanjkanje vitamina D),
English: Bonviva 150 mg once monthly
Slovenian: Bonviva 150 mg enkrat na mesec
English: Bonviva, like other bisphosphonates administered intravenously, may cause a transient decrease in serum calcium values.
Slovenian: Zdravilo Bonviva lahko, tako kot drugi difosfonati, ki jih dajemo intravensko, povzroči prehodno zmanjšanje serumskih vrednosti kalcija.
English: Bonviva may help lower the chances of breaking bones (fractures).
Slovenian: Zdravilo Bonviva pomaga zmanjšati možnost zloma.
English: After you have taken Bonviva, please wait for 1 hour before you can have your first food and further drinks.
Slovenian: Po tem, ko ste vzeli zdravilo Bonviva, prosimo, počakajte 1 uro, preden zaužijete prvo hrano in nadaljnjo pijačo (glejte poglavje 3.
English: Elderly population (>65 years) No dose adjustment is required (see section 5.2).
Slovenian: Starejši bolniki (> 65 let) Prilagajanje odmerkov ni potrebno (glejte poglavje 5.2).
English: - Water is the only drink that should be taken with Bonviva.
Slovenian: - Voda je edina tekočina, ki jo lahko bolnik zaužije z zdravilom Bonviva.
English: Bonviva tablets are white to off white, of oblong shape and marked “BNVA” on one side, and “150” on the other side.
Slovenian: Bonviva tablete so bele do sivo bele barve, podolgovate oblike z oznako “BNVA” na eni strani in “150” na drugi strani.
English: Milk or antacids should be given to bind Bonviva, and any adverse reactions treated symptomatically.
Slovenian: Za vezavo zdravila Bonviva je treba zaužiti mleko ali antacide, neželene učinke pa zdravimo simptomatično.
English: No specific information is available on the treatment of overdosage with Bonviva.
Slovenian: Specifičnih informacij o zdravljenju prevelikega odmerjanja zdravila Bonviva ni na voljo.
English: What Bonviva is and what it is used for What you need to know before you receive Bonviva How to receive Bonviva
Slovenian: Kaj je zdravilo Bonviva in za kaj ga uporabljamo Kaj morate vedeti, preden boste prejeli zdravilo Bonviva Kako prejemati zdravilo Bonviva Možni neželeni učinki
English: Bonviva 3 mg solution for injection in pre-filled syringe must not be mixed with calcium-containing solutions (such as Ringer-Lactate solution, calcium heparin) or other intravenously administered medicinal products.
Slovenian: Zdravila Bonviva 3 mg raztopina za injiciranje v napolnjeni injekcijski brizgi ne smemo mešati z raztopinami, ki vsebujejo kalcij (kot je raztopina Ringerjevega laktata, kalcijev heparin) ali drugimi intravensko dajanimi zdravili.
English: One year data in study BM 16550 Two year data in study BM 16550
Slovenian: Dveletni podatki iz študije BM 16550
English: How to take Bonviva).
Slovenian: Kako jemati zdravilo Bonviva).
English: Bonviva contains less than 1 mmol sodium (23 mg) per dose (3 ml), i.e. essentially “sodium-free”.
Slovenian: Zdravilo Bonviva vsebuje manj kot 1 mmol (23 mg) natrija na odmerek (3 ml), kar v bistvu pomeni ‛brez natrija'.
English: While on treatment, invasive dental procedures should be performed only after careful consideration and be avoided in close proximity to Bonviva administration.
Slovenian: Invazivne zobozdravstvene posege se lahko med zdravljenjem opravi le po temeljitem razmisleku, zlasti se jim je treba izogibati v času blizu termina prejema zdravila Bonviva.
English: Existing hypocalcaemia must be corrected before starting Bonviva therapy.
Slovenian: Obstoječo hipokalcemijo je treba popraviti pred začetkom zdravljenja z zdravilom Bonviva.
English: Some people need to be especially careful while they're taking Bonviva.
Slovenian: Nekateri ljudje morajo biti pri jemanju zdravila Bonviva še posebno previdni.
English: Contains 154.6 mg anhydrous lactose (equivalent to 162.75 mg lactose monohydrate).
Slovenian: Pomožne snovi z znanim učinkom: vsebuje 154,6 mg brezvodne laktoze (enakovredno 162,75 mg laktoze monohidrata).
English: What you need to know before you receive Bonviva
Slovenian: Kaj morate vedeti, preden boste prejeli zdravilo Bonviva
English: Patients treated with Bonviva should be given the package leaflet and the patient reminder card.
Slovenian: Bolnikom, ki prejemajo zdravilo Bonviva, je treba izročiti navodilo za uporabo in opozorilno kartico za bolnika.
English: Bonviva is available in packs of 1 pre-filled syringe and 1 injection needle or 4 pre-filled syringes and 4 injection needles.
Slovenian: Bonviva je na voljo v pakiranju po 1 napolnjeno injekcijsko brizgo in 1 injekcijsko iglo ali po 4 napolnjene injekcijske brizge in 4 injekcijske igle.
English: Bonviva is for use only by postmenopausal women and must not be taken by women who could still have a baby.
Slovenian: Zdravilo Bonviva se uporablja samo pri ženskah po menopavzi, ženske, ki še lahko imajo otroka, pa ga ne smejo jemati.
English: Bonviva 150 mg once monthly (N=320)
Slovenian: Bonviva 150 mg enkrat na mesec (n = 320)
English: Therefore, patients should fast overnight (at least 6 hours) before taking Bonviva and continue fasting for 1 hour following intake of Bonviva (see section 4.2).
Slovenian: Zato morajo bolniki jemati zdravilo Bonviva zjutraj na prazen želodec (vsaj 6 ur brez obroka), po zaužitju zdravila Bonviva pa morajo biti še 1 uro tešči (glejte poglavje 4.2).
English: NAME OF THE MEDICINAL PRODUCT Bonviva 150 mg film-coated tablets
Slovenian: IME ZDRAVILA Bonviva 150 mg filmsko obložene tablete
English: Frequency categories are defined using the following convention: very common (>1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000),very rare (<1/10,000), not known (cannot be estimated from the available data).
Slovenian: Neželeni učinki so navedeni po organskih sistemih in pogostnosti po MedDRA. Glede na pogostnost so neželeni učinki opredeljeni kot zelo pogosti (≥1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1000 do < 1/100), redki (≥ 1/10.000 do < 1/1000), zelo redki (< 1/10.000), z neznano pogostnostjo (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti).
English: Bonviva 3 mg injection every 3 months (N=365)
Slovenian: Bonviva 3 mg v obliki injekcije vsake 3 mesece (n = 334)
English: Bonviva should not be used during breastfeeding.
Slovenian: Zdravila Bonviva se med dojenjem ne sme uporabljati.
English: Planning when to take Bonviva with peel-off stickers for your personal calendar What Bonviva is and what it is used for What you need to know before you take Bonviva How to take Bonviva
Slovenian: Kaj vsebuje navodilo Načrtovanje jemanja zdravila Bonviva z nalepkami za vaš osebni koledar Kaj je zdravilo Bonviva in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Bonviva Kako jemati zdravilo Bonviva Možni neželeni učinki 5 Shranjevanje zdravila Bonviva Vsebina pakiranja in dodatne informacije
English: All patients should be encouraged to maintain good oral hygiene, undergo routine dental check-ups, and immediately report any oral symptoms such as dental mobility, pain or swelling, or non-healing of sores or discharge during treatment with Bonviva.
Slovenian: Vsem bolnikom je treba naročiti, naj med zdravljenjem z zdravilom Bonviva skrbijo za dobro ustno higieno in redno opravljajo preglede pri zobozdravniku, v primeru simptomov v ustni votlini, kot so majavost zob, bolečina, oteklina, slabo celjenje ali izcedek iz ran, pa naj takoj obvestijo zdravnika.
English: Bonviva solution for injection must not be mixed with calcium-containing solutions or other intravenously administered medicinal products.
Slovenian: Zdravila Bonviva, raztopine za injiciranje, ne smemo mešati z raztopinami, ki vsebujejo kalcij, ali drugimi intravensko dajanimi zdravili.
English: The overall proportion of patients who experienced an adverse reaction, was 22.7 % and 25.0 % for Bonviva 150 mg once monthly after one and two years, respectively.
Slovenian: Celoten delež bolnikov, pri katerih se je pojavil neželeni učinek, je bil 22,7 % za zdravilo Bonviva 150 mg enkrat na mesec po enem letu in 25,0 % po dveh letih.
English: Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Bonviva is given to patients with active upper gastrointestinal problems (e.g. known Barrett's oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Slovenian: Zaradi možnih dražečih učinkov ter možnega poslabšanja predhodne bolezni je treba zdravilo Bonviva pri bolnikih z aktivnimi obolenji zgornjega dela prebavil (npr. potrjenim Barrettovim požiralnikom, disfagijo, drugimi boleznimi požiralnika, gastritisom, duodenitisom ali razjedami) uporabljati previdno.
English: Bonviva is essentially sodium free.
Slovenian: Zdravilo Bonviva je praktično brez natrija.
English: Bonviva 150 mg film-coated tablets Ibandronic acid
Slovenian: Bonviva 150 mg filmsko obložene tablete ibandronska kislina
English: Due to the limited clinical experience, Bonviva is not recommended in patients with severe renal impairment (see section 4.2 and section 4.4).
Slovenian: Zaradi omejenih kliničnih izkušenj jemanje zdravila Bonviva pri bolnikih s hudo okvaro ledvic ni priporočljivo (glejte poglavje 4.2 in poglavje 4.4).
English: Existing hypocalcaemia must be corrected before starting Bonviva injection therapy.
Slovenian: Obstoječo hipokalcemijo je treba popraviti pred začetkom zdravljenja z zdravilom Bonviva v obliki injekcije.
English: • If you have, or had in the past low blood calcium.
Slovenian: • če imate znižano koncentracijo kalcija v krvi, ali ste jo imeli v preteklosti.
English: Where Bonviva is administered via an existing intravenous infusion line, the intravenous infusate should be restricted to either isotonic saline or 50 mg/ml (5 %) glucose solution.
Slovenian: Kjer zdravilo Bonviva dajemo skozi obstoječi intravenski infuzijski kanal, je intravenski infuzat lahko le izotonična raztopina natrijevega klorida ali 50 mg/ml (5-%) raztopina glukoze.
English: Bonviva 3 mg intravenous injection, administered every 3 months, was shown to be at least as effective as oral ibandronic acid 2.5 mg daily in a 2-year, randomised, double-blind, multicentre, noninferiority study (BM16550) of postmenopausal women (1386 women aged 55 - 80) with osteoporosis (lumbar spine BMD T-score below -2.5 SD at baseline).
Slovenian: Zdravilo Bonviva v obliki 3-mg intravenske injekcije, ki se daje vsake 3 mesece, se je izkazalo za najmanj enako učinkovito kakor ibandronska kislina 2,5 mg enkrat na dan peroralno v dveletni randomizirani, dvojno slepi, multicentrični, neinferiorni študiji (BM 16550) pri ženskah z osteoporozo v postmenopavzi (1.386 žensk, starih 55 do 80 let z izhodiščno T-vrednostjo MKG ledvene hrbtenice pod -2,5 SD).
English: After one year (primary analysis) the median relative change from baseline was -76 % for Bonviva 150 mg once monthly and -67 % for ibandronic acid 2.5 mg daily.
Slovenian: Po enem letu (primarna analiza) je bila mediana relativne spremembe od izhodiščne vrednosti -76 % za zdravilo Bonviva 150 mg enkrat na mesec in -67 % za ibandronsko kislino 2,5 mg enkrat na dan.
English: Bonviva 3 mg injection every 3 months
Slovenian: Bonviva 3 mg v obliki injekcije vsake 3 mesece
English: • smoking, or drinking too much alcohol
Slovenian: • kajenje ali čezmerno pitje alkohola,
English: The most serious reported adverse reactions are anaphylactic reaction/shock, atypical fractures of the femur, osteonecrosis for the jaw and ocular inflammation (see paragraph “Description of selected adverse reactions” and section 4.4).
Slovenian: Najbolj resni poročani neželeni učinki so anafilaktične reakcije/šok, atipični zlomi stegnenice, osteonekroza čeljustnic, draženje prebavil, vnetje oči (glejte odstavek »Opis izbranih neželenih učinkov« in poglavje 4.4).
English: However, since this increase is within the normal variability of the bioavailability of ibandronic acid, no dose adjustment is considered necessary when Bonviva is administered with H2antagonists or other active substances which increase gastric pH.
Slovenian: Ker je to zvečanje v mejah normalne variabilnosti biološke uporabnosti ibandronske kisline, pri sočasnem jemanju zdravila Bonviva z antagonisti histaminskih receptorjev H2 ali drugimi zdravili, ki zvečajo pH želodca, prilagajanje odmerkov ni potrebno.
English: Bonviva 3 mg solution for injection in pre-filled syringes is a clear colourless solution.
Slovenian: Bonviva 3 mg raztopina za injiciranje v napolnjeni injekcijski brizgi je bistra, brezbarvna raztopina.
English: Ocular inflammation*†
Slovenian: Očesne bolezni vnetje oči*†
English: What you need to know before you take Bonviva
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Bonviva
English: Appropriate medical support and monitoring measures should be readily available when Bonviva intravenous injection is administered.
Slovenian: Pri dajanju intravenske injekcije zdravila Bonviva mora biti na voljo ustrezna medicinska podpora in nadzor.
English: Based on the results of study BM 16549, Bonviva 150 mg once monthly is expected to be at least as effective in preventing fractures as ibandronic acid 2.5 mg daily.
Slovenian: Glede na rezultate študije BM 16549 pričakujemo, da je zdravilo Bonviva 150 mg enkrat na mesec najmanj enako učinkovito v preprečevanju zlomov kakor ibandronska kislina 2,5 mg enkrat na dan.
English: PEEL-OFF STICKERS FOR YOUR PERSONAL CALENDAR Monthly tablet
Slovenian: NALEPKE ZA VAŠ OSEBNI KOLEDAR Mesečna tableta Mesečna tableta Mesečna tableta Bonviva
English: Since Acetylsalicylic acid, Nonsteroidal Anti-Inflammatory medicinal products (NSAIDs) and bisphosphonates are associated with gastrointestinal irritation, caution should be taken during concomitant administration (see section 4.4).
Slovenian: Acetilsalicilna kislina in nesteroidna protivnetna zdravila Ker so acetilsalicilna kislina, nesteroidna protivnetna zdravila in difosfonati povezani z draženjem prebavil, je med sočasnim dajanjem potrebna previdnost (glejte poglavje 4.4).
English: In a two-year study in postmenopausal women with osteoporosis (BM 16549) the overall safety of Bonviva 150 mg once monthly and ibandronic acid 2.5 mg daily was similar.
Slovenian: V dveletni študiji pri ženskah z osteoporozo v postmenopavzi (BM 16549) je bila celokupna varnost zdravila Bonviva 150 mg enkrat na mesec in ibandronske kisline 2,5 mg enkrat na dan podobna.
English: The overall proportion of patients who experienced an adverse reaction was 26.0 % and 28.6 % for Bonviva 3 mg injection every 3 months after one year and two years, respectively.
Slovenian: Celoten delež bolnikov, ki so imeli neželeni učinek, je bil 26,0 % za zdravilo Bonviva 3 mg v obliki injekcije, dane vsake 3 mesece, po enem letu in 28,6 % po dveh letih.
English: A dental examination with preventive dentistry and an individual benefit-risk assessment is recommended prior to treatment with Bonviva in patients with concomitant risk factors.
Slovenian: Pri bolnikih s spremljajočimi dejavniki tveganja je pred začetkom zdravljenja z zdravilom Bonviva priporočljivo opraviti zobozdravniški pregled z ustreznimi preventivnimi zobozdravstvenimi ukrepi in oceniti razmerje med koristmi in tveganji pri vsakem posameznem bolniku.
English: Physicians should be alert to any signs or symptoms signaling a possible oesophageal reaction and patients should be instructed to discontinue Bonviva and seek medical attention if they develop dysphagia, odynophagia, retrosternal pain or new or worsening heartburn.
Slovenian: Zdravniki morajo biti pozorni na znake ali simptome, ki opozarjajo na možno reakcijo v požiralniku, bolnikom pa je treba naročiti, da naj v primeru če se pri njih pojavijo disfagija, odinofagija,
English: Calcium supplements, antacids and some oral medicinal products containing multivalent cations Calcium supplements, antacids and some oral medicinal products containing multivalent cations (such as aluminium, magnesium, iron) are likely to interfere with the absorption of Bonviva.
Slovenian: Dodatki kalcija, antacidi in nekatera peroralna zdravila, ki vsebujejo večvalentne katione Dodatki kalcija, antacidi in nekatera peroralna zdravila, ki vsebujejo večvalentne katione (kot so aluminij, magnezij, železo), lahko vplivajo na absorpcijo zdravila Bonviva, zato bolniki najmanj 6 ur pred ter še 1 uro po zaužitju zdravila Bonviva ne smejo jemati drugih peroralnih zdravil.
English: • If you forgot to take your tablet on your chosen day and your next scheduled dose is only 1 to 7 days away…
Slovenian: • Če ste pozabili vzeti tableto na vaš izbrani dan in je do vašega naslednjega načrtovanega odmerka le 1 do 7 dni … ne vzemite dveh tablet zdravila Bonviva v istem tednu.
English: Bonviva 3 mg solution for injection in pre-filled syringe like other bisphosphonates administered intravenously, may cause a transient decrease in serum calcium values.
Slovenian: Bonviva 3 mg raztopina za injiciranje v napolnjeni injekcijski brizgi lahko kot drugi intravensko dajani difosfonati povzroči prehodno zmanjšanje koncentracije kalcija v serumu.